Summary
We aim to develop a new diagnostic assay and want to revolutionize clinical decision making through the (overdue) implementation of high throughput data into the clinical routine.
Impending changes
Precision medicine will not be possible without the integration of complex datasets and we think that a paradigm shift is under way: From the Focus of on single disease surrogate markers to molecular fingerprint diagnostics. The pathogenesis of disease is as complex and individual as the human experiencing it. We should account for that variability between humans with a flexible approach to treatment options. Physicians agree on this, but buerocracy moves slowly and the development of new strategies is very time and cost effective.
Unclaimed territory
Politics start to recognize this window of opportunity and legislation will soon create now windows of opportunity. We aim to fill this net unclaimed space with our innovative approach to diagnostics.